About Morphocell Technologies
Morphocell Technologies is a company based in Montreal (Canada) founded in 2018.. Morphocell Technologies has raised $50 million across 3 funding rounds from investors including CQDM, Invest Quebec and CDP Venture Capital. Morphocell Technologies offers products and services including ReLiver. Morphocell Technologies operates in a competitive market with competitors including NGM Biopharmaceuticals, Avidity Biosciences, Nimbus Therapeutics, Univercells and Sutro Biopharma, among others.
- Headquarter Montreal, Canada
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$50 M (USD)
in 3 rounds
-
Latest Funding Round
$10 M (USD), Series A
Dec 01, 2025
-
Investors
CQDM
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Morphocell Technologies
Morphocell Technologies offers a comprehensive portfolio of products and services, including ReLiver. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops tissue for treating liver diseases via advanced engineering.
Unlock access to complete
Unlock access to complete
Funding Insights of Morphocell Technologies
Morphocell Technologies has successfully raised a total of $50M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $10 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $10.0M
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2025 | Amount | Series A - Morphocell Technologies | Valuation | Invest Quebec , CDP Venture Capital |
|
| Feb, 2024 | Amount | Series A - Morphocell Technologies | Valuation | Genson Capital |
|
| Jul, 2021 | Amount | Seed - Morphocell Technologies | Valuation | CQDM |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Morphocell Technologies
Morphocell Technologies has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include CQDM, Invest Quebec and CDP Venture Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CQDM is focused on facilitating biopharma innovation through funding.
|
Founded Year | Domain | Location | |
|
Venture capital and fund of funds focused on multiple sectors
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Morphocell Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Morphocell Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Morphocell Technologies Comparisons
Competitors of Morphocell Technologies
Morphocell Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NGM Biopharmaceuticals, Avidity Biosciences, Nimbus Therapeutics, Univercells and Sutro Biopharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biologics are developed for cardio-metabolic and liver diseases.
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Morphocell Technologies
Frequently Asked Questions about Morphocell Technologies
When was Morphocell Technologies founded?
Morphocell Technologies was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Where is Morphocell Technologies located?
Morphocell Technologies is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
Is Morphocell Technologies a funded company?
Morphocell Technologies is a funded company, having raised a total of $50M across 3 funding rounds to date.
What does Morphocell Technologies do?
Morphocell Technologies was founded in 2018 in Montreal, Canada, within the biotechnology sector. ReLiver, an engineered liver tissue, is utilized to create an implantable device for acute-on-chronic liver failure, an extracorporeal bio-artificial liver device, and in vitro assays for drug discovery. Operations focus on advancing these medical technologies to address liver-related conditions.
Who are the top competitors of Morphocell Technologies?
Morphocell Technologies's top competitors include Sutro Biopharma, Nimbus Therapeutics and Avidity Biosciences.
What products or services does Morphocell Technologies offer?
Morphocell Technologies offers ReLiver.
Who are Morphocell Technologies's investors?
Morphocell Technologies has 4 investors. Key investors include CQDM, Invest Quebec, CDP Venture Capital, and Genson Capital.